What is Allan-Herndon-Dudley Syndrome

Allan-Herndon-Dudley syndrome is a rare, X-linked genetic disorder characterized by intellectual disability and severe motor impairment caused by abnormal thyroid hormone signaling in the brain. It primarily affects males and is caused by mutations in the SLC16A2 gene, which prevents the proper transport of thyroid hormones into neurons.

What are the primary symptoms of Allan-Herndon-Dudley syndrome?

The clinical presentation of Allan-Herndon-Dudley syndrome typically emerges in early infancy. Patients often exhibit hypotonia (low muscle tone), which later progresses to muscle stiffness (spasticity), joint contractures, and severe muscle wasting. Because the brain requires specific thyroid hormones to develop correctly, individuals with Allan-Herndon-Dudley syndrome experience significant cognitive impairment and delayed motor milestones, such as the inability to sit independently or walk.

How is Allan-Herndon-Dudley syndrome inherited?

Allan-Herndon-Dudley syndrome follows an X-linked recessive inheritance pattern. This means the condition is caused by a mutation on the X chromosome. Because males have only one X chromosome, they are almost exclusively affected by the disorder. Females, who have two X chromosomes, are typically carriers and usually do not display the severe symptoms associated with Allan-Herndon-Dudley syndrome.

What causes this condition at the cellular level?

The underlying mechanism involves the SLC16A2 gene, which provides instructions for making the MCT8 protein. This protein acts as a transporter to bring thyroid hormones into nerve cells. Key features of the pathophysiology include:

• Thyroid Hormone Imbalance: While blood tests often show high levels of T3 (triiodothyronine) and low levels of T4 (thyroxine), the brain remains "starved" of these hormones.


• Neurological Impact: The lack of thyroid hormone inside the brain cells leads to impaired neuronal development and function.


• Diagnostic Differentiation: Unlike typical thyroid disorders, the thyroid hormone levels in Allan-Herndon-Dudley syndrome are a result of the transport defect, not a primary thyroid gland malfunction.

How common is Allan-Herndon-Dudley syndrome?

Allan-Herndon-Dudley syndrome is an extremely rare condition. While the exact prevalence is unknown, it is considered underdiagnosed. At DiseaseMaps.org, we currently have 8 community members documenting their experiences, highlighting the importance of connecting families within this small global population.

Next steps

• Consult a clinical geneticist to discuss SLC16A2 genetic testing.


• Connect with the 8 members currently registered on DiseaseMaps.org to share insights.


• Work with a multidisciplinary team, including neurologists and endocrinologists, to manage symptoms like spasticity and seizures.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Allan-Herndon-Dudley Syndrome.


• Orphanet: Rare Disease Database (ORPHA: 76).


• Online Mendelian Inheritance in Man (OMIM): Entry #300523 (MCT8 Deficiency).


• PubMed: Clinical and genetic literature on SLC16A2-related disorders.